Human telomerase reverse transcriptase, p53 and Ki-67 expression and apoptosis in colorectal serrated adenoma

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 10, 2002, Pages 1194-1200

  Oka, S ^a   Tanaka, Shinji ^a   Hiyama, T ^a   Kitadai, Y ^a   Yoshihara, M ^a   Shimamoto, F ^a   Haruma, K ^a   Chayama, K ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Human telomerase reverse transcriptase (hTERT); Hyperplastic polyp; In situ mRNA hybridization; Ki 67; p53; Serrated adenoma

Indexed keywords

DNA; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN P53; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

APOPTOSIS; ARTICLE; CANCER GRADING; COLON ADENOMA; COLON POLYP; COLORECTAL CARCINOMA; DNA SEQUENCE; DNA STRAND BREAKAGE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECTUM ADENOMA; SEQUENCE HOMOLOGY;

ADENOMA; APOPTOSIS; CARCINOMA IN SITU; COLON; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; HYPERPLASIA; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; KI-67 ANTIGEN; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036794879     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655202760373416     Document Type: Article

References (38)

1. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 1990;14:524-37.
2. Matsumoto T, Mizuno M, Shimizu M, Manabe T, Iida M. Clinicopathological features of serrated adenomas of the colorectum: comparison with traditional adenoma. J Clin Pathol 1999;52:513-6.
3. Matsumoto T, Mizuno M, Shimizu M, Nakamura S, Fujishima M. Serrated adenoma of the colorectum: colonoscopic and histologic features. Gastrointest Endosc 1999;49:736-42.
4. Yao T, Kouzuki T, Kajiwara M, Matsui N, Oya M, Tsunezumi M. Serrated adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential. J Pathol 1999;187:511-7.
5. Iwabuchi M, Sasano H, Hiwatashi N, Hiwatashi N, Masuda T, Shimosegawa T, et al. Serrated adenoma: a clinicopathological, DNA ploidy, and immunohistochemical study. Anticancer Res 2000;20:1141-8.
6. Shimamoto F, Tanaka S, Tahara E. Pathogenesis of serrated adenoma of the colorectum: implication for malignant progression. In: Tahara E, editor. Molecular pathology of gastroenterological cancer: application to clinical practice. Tokyo: Springer-Verlag; 1997. p. 93-106.
7. Shimamoto F, Tanaka S, Hiraga Y, Hiyama T, Tahara E. Cell proliferation in polypoid type and superficial type serrated adenomas of the colorectum. In: Tahara E, Sugimachi K, editors. Recent advances in gastroenterological carcinogenesis I. Bologna: Monduzzi Editore; 1996. p. 773-8.
8. Makinen MJ, George SM, Jernvall P, Makela J, Vihko P, Karttunen TJ. Colorectal carcinoma associated with serrated adenoma-prevalence, histological features, and prognosis. J Pathol 2001;193:286-94.
9. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology 1996;110:748-55.
10. Jass JR. Serrated adenoma and colorectal cancer. J Pathol 1999;187:499-502.
11. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989;59:521-9.
12. Greider CW, Blackburn EH. A telomic sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 1989:337:331-7.
13. Nakamura TM, Morin GB, Chapman KB. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997;277:955-9.
14. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997;90:785-95.
15. Tahara H, Yasui W, Tahara E, Fujimoto J, Ito K, Tamai K, et al. Immunohistochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 1999:18:1561-7.
16. Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 1998;19:182-6.
17. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998;18:65-8.
18. Tanaka S, Haruma K, Tatsuta S, Hiraga Y, Teixira CR, Shimamoto F, et al. Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma. Oncology 1995;52:134-9.
19. Teixeria CR, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, et al. Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer 1994;73:575-9.
20. Moss SF, Scholes JV, Holt PR. Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling. Dig Dis Sci 1996;41:2238-47.
21. Hashimoto S, Koji T, Kohara N, Kanematsu T, Nakane PK. Frequency of apoptosis relates inversely to invasiveness and metastatic activity in human colorectal cancer. Virchows Arch 1997;431:241-8.
22. Baker SJ, Presinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JK, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-22.
23. Bertorelle R, Esposito G, Mistro A, Belluco C, Nitti D, Lise M, et al. Association of p53 gene and protein alterations with metastasis in colorectal cancer. Am J Surg Pathol 1993;19:463-71.
24. Stanley RH, Lauri AA. World Health Organization Classification of Tumours. IARC Press: Lyon; 2000. p. 104-19.
25. Park CS, Brigati DJ, Manahan LJ. Automated molecular pathology: one hour in situ DNA hybridization. J Histotechnol 1991;14:219-29.
26. Greene GF, Kitadai Y, Pettaway CA, von Eschenbach AC, Bucana CD, Fidler IJ. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am J Pathol 1997;150:1571-82.
27. Falchetti ML, Pallini R, D'Ambrosio E, Pierconti F, Martini M, Cimino-Reale G, et al. In situ detection of telomerase catalytic subunit mRNA in glioblastomamultiforme. Int J Cancer 2000;88;895-901.
28. Kammori M, Kanauchi H, Nakamura K, Kawahara M, Weber TK, Mafune K, et al. Demonstration of human colorectal carcinomas by in situ hybridyzation. Int J Oncol 2002;20:15-21.
29. Xu D, Wang Q, Gruber A, Bjorkholm M, Chen Z, Zaid A, et al. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 2000;19:5123-33.
30. Hiyama T, Yokozaki H, Shimamoto F, Haruma K, Yasui W, Kajiyama G, et al. Frequent p53 gene mutations in serrated adenomas of the colorectum. J Pathol 1998;186:131-9.
31. Rublo CA, Rodenso M. p53 overexpression in flat serrated adenomas and flat tubular adenomas of the colorectal mucosa. J Cancer Res Clin Oncol 1995;121:571-6.
32. Fearon E, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
33. Kang M, Mitomi H, Sada M, Tokumitsu Y, Takahashi Y, Igarashi M, et al. Ki-67, p53, and Bcl-2 expression of serrated adenomas of the colon. Am J Surg Pathol 1997;21:417-23.
34. Iino H, Jass JR, Simms LA, Young J, Leggett B, Ajioka Y, et al. DNA microsatellite instability in hyperplastic polyps, serrated adenomas and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol 1999;52:5-9.
35. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
36. Tanimoto T, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, et al. Growth patterns in various macroscopic types of noninvasive intramucosal colorectal carcinoma with special reference to apoptosis and cell proliferation. Dis Colon Rectum 1998;41:1376-84.
37. MacNamara B, Wang W, Chen Z, Hou M, Mazur J, Gruber A, et al. Telomerase activity in relation to pro- and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas. Haematologica 2001;86:386-93.
38. Zhang Z, Liong EC, Lau TY, Leung KM, Fung PCW, Tipoe GL. Induction of apoptosis by hexamethylene bisacetamide is p53-dependent associated with telomerase activity but not with terminal differentiation. Int J Oncol 2000;16:887-92.